Concepedia

Matthew W. Harding

MW

41

Publications

9K

Citations

29

H-Index

1984

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Yale University

Dana-Farber Cancer Institute

Harvard University

Matthew W. Harding is an author at Vertex Pharmaceuticals (United States) specializing in medicine, immunology, and pharmacology.

Top concepts

Publications per year

1984–2008

41

Publications

41

Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A

Robert E. Handschumacher, Matthew W. Harding, Jeffrey S. Rice et al. · Science · 1984 · 1.7K citations

Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme

Keisuke Kuida, Judith A. Lippke, George Ku et al. · Science · 1995 · 1.6K citations

, , +17

A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase

Matthew W. Harding, David Uehling, Stuart L. Schreiber · Nature · 1989 · 1.4K citations

, , +7

Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme

Yong Gu, Keisuke Kuida, Hiroko Tsutsui et al. · Science · 1997 · 1.1K citations

Isolation and amino acid sequence of cyclophilin.

Matthew W. Harding, Robert E. Handschumacher, David W. Speicher · Journal of Biological Chemistry · 1986 · 290 citations · Full text

Rows per page

1–5 of 41